Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.

McCormack B, Bacchetti A, Lin T-Y, Moretti GS, Filippatou A, Gakis G, O'Donnell M M, Lambert C MG, Lee NJ, Ecoff K, et al.